Lithium associated autoimmune thyroiditis. 1997

M Shimizu, and M Hirokawa, and T Manabe, and K Shimozuma, and H Sonoo, and T Harada
Department of Pathology, Kawasaki Medical School, Okayama, Japan.

A case of autoimmune thyroiditis after long term treatment with lithium is described in a 29 year old Japanese woman with manic depression. Positive serum antithyroglobulin and antimicrosomal antibodies, diffuse goitre, and microscopic chronic thyroiditis, as well as the clinical history of long term lithium treatment were suggestive of lithium associated autoimmune thyroiditis. Microscopically, there was a mild degree of interstitial fibrosis and a moderate degree of lymphocytic infiltration. Some areas showed a moderate degree of stromal fibrosis and atrophic thyroid follicles. Lymphoid follicles with germinal centres, disrupted thyroid follicles with lymphocytic infiltration, and Hürthle cells were also observed. The differential diagnosis in patients presenting with these histological features includes painless (silent) thyroiditis, autoimmune thyroiditis and lithium associated autoimmune thyroiditis. A detailed clinical history is essential if the correct diagnosis is to be reached.

UI MeSH Term Description Entries
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D001714 Bipolar Disorder A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. Affective Psychosis, Bipolar,Bipolar Disorder Type 1,Bipolar Disorder Type 2,Bipolar Mood Disorder,Depression, Bipolar,Manic Depression,Manic Disorder,Manic-Depressive Psychosis,Psychosis, Manic-Depressive,Type 1 Bipolar Disorder,Type 2 Bipolar Disorder,Psychoses, Manic-Depressive,Bipolar Affective Psychosis,Bipolar Depression,Bipolar Disorders,Bipolar Mood Disorders,Depression, Manic,Depressions, Manic,Disorder, Bipolar,Disorder, Bipolar Mood,Disorder, Manic,Manic Depressive Psychosis,Manic Disorders,Mood Disorder, Bipolar,Psychoses, Bipolar Affective,Psychoses, Manic Depressive,Psychosis, Bipolar Affective,Psychosis, Manic Depressive
D013967 Thyroiditis, Autoimmune Inflammatory disease of the THYROID GLAND due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific T-CELLS and thyroid AUTOANTIBODIES. The clinical signs can range from HYPOTHYROIDISM to THYROTOXICOSIS depending on the type of autoimmune thyroiditis. Autoimmune Thyroiditis,Thyroiditis, Lymphocytic,Thyroiditis, Lymphomatous,Autoimmune Thyroiditides,Lymphocytic Thyroiditides,Lymphocytic Thyroiditis,Lymphomatous Thyroiditides,Lymphomatous Thyroiditis,Thyroiditides, Autoimmune,Thyroiditides, Lymphocytic,Thyroiditides, Lymphomatous
D016651 Lithium Carbonate A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems. CP-15,467-61,Dilithium Carbonate,Eskalith,Lithane,Lithium Bicarbonate,Lithobid,Lithonate,Lithotabs,Micalith,NSC-16895,Priadel,Quilinorm-retard,Bicarbonate, Lithium,CP 15,467 61,CP15,46761,Carbonate, Dilithium,Carbonate, Lithium,NSC 16895,NSC16895,Quilinorm retard,Quilinormretard

Related Publications

M Shimizu, and M Hirokawa, and T Manabe, and K Shimozuma, and H Sonoo, and T Harada
January 2002, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
M Shimizu, and M Hirokawa, and T Manabe, and K Shimozuma, and H Sonoo, and T Harada
June 1993, The Australian and New Zealand journal of psychiatry,
M Shimizu, and M Hirokawa, and T Manabe, and K Shimozuma, and H Sonoo, and T Harada
October 2005, Thyroid : official journal of the American Thyroid Association,
M Shimizu, and M Hirokawa, and T Manabe, and K Shimozuma, and H Sonoo, and T Harada
October 2016, Journal of child and adolescent psychopharmacology,
M Shimizu, and M Hirokawa, and T Manabe, and K Shimozuma, and H Sonoo, and T Harada
November 1985, The American journal of psychiatry,
M Shimizu, and M Hirokawa, and T Manabe, and K Shimozuma, and H Sonoo, and T Harada
October 2013, The Australian and New Zealand journal of psychiatry,
M Shimizu, and M Hirokawa, and T Manabe, and K Shimozuma, and H Sonoo, and T Harada
January 1987, La Revue de medecine interne,
M Shimizu, and M Hirokawa, and T Manabe, and K Shimozuma, and H Sonoo, and T Harada
June 2005, The Korean journal of internal medicine,
M Shimizu, and M Hirokawa, and T Manabe, and K Shimozuma, and H Sonoo, and T Harada
January 2004, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia,
M Shimizu, and M Hirokawa, and T Manabe, and K Shimozuma, and H Sonoo, and T Harada
January 2011, Journal of pediatric endocrinology & metabolism : JPEM,
Copied contents to your clipboard!